We’re excited to announce our $200M Series D fundraise led by Double Point Ventures, with @khoslaventures, ARCH Ventures, Bezos Expeditions, NRF, NTI, METIS, @protocollabs@K5Global and others. 🧠🧠
Read the release:
https://t.co/0spN7uh9WZ
Neurotech is Humanity’s Next Frontier!
I’ve been investing in neurotech since 2021 and working with teams building BCIs, NeuroAI, and connectomics. It now feels like AI did in ~2019.
We are entering an extraordinary era: neurotech already restores functions, it can enhance our capabilities, and will evolve what it means to be human.
PLC Neurotech is the fund backing the extraordinary founders and defining companies of this booming industry.
Excited to share we made the @FastCompany Most Innovative Companies 2026 list in the Data Science category. 🔥🔥🔥
View the list: https://t.co/iqOJwJv04N
#FCMostInnovative#BCI
Neuralink rival company @synchroninc just raised $200 million.
Their CEO @tomoxl joined TITV to explain his plans.
Watch the full episode: https://t.co/bAdl9nQxbH
Company targets pivotal trials of brain-computer interface platform that allows control of digital devices using thought alone.
https://t.co/O2Lq8GhNrD
#neurotech#longevity#investment#BCI#technology
We’re excited to announce our $200M Series D fundraise led by Double Point Ventures, with @khoslaventures, ARCH Ventures, Bezos Expeditions, NRF, NTI, METIS, @protocollabs@K5Global and others. 🧠🧠
Read the release:
https://t.co/0spN7uh9WZ
Markets eye a potential tariff rollback while Evommune and @Aeromexico will make their Wall Street debuts on the NYSE. Elsewhere, @synchroninc announces it raised $200 Million in Series D funding. @Ash_TV has more in the market update.
➡️ Follow @NYSE for the daily Market Update
We’re excited to return as exhibitors at #ALSNexus2025, hosted by @alsassociation, an event where leaders across research, care, and advocacy come together to drive progress for the #ALS community.
Meet us at Booth #102.
More info: https://t.co/kuFiRHGEXI
During @theCUBE + @NYSE Wired: Medtech Unplugged Series, @dvellante spoke to @KurtHaggstrom about @Synchroninc’s Brain Computer Interface (BCI) & how it’s less invasive, & more scalable & durable than Neuralink.
💡 More insights:
https://t.co/ftiF5SaUWg
@furrier@bjbaumann2014
Synchron combines brain implant with @Apple's BCI protocol to enable control of consumer electronic devices via neural signals.
https://t.co/2cG6QPXYDp
#longevity#neurotech#BCI#iPad#ALS
You can officially control an Apple device with your thoughts, as long as you have the Stentrode brain implant made by NYC-based Synchron.
https://t.co/SSly9RR77k
Apple's new thought control protocol has now been shown in use by Synchron, a medical company that has made a prototype for using iPads solely by thinking. By @WGallagher
https://t.co/Simwvv07VP